<DOC>
	<DOCNO>NCT00070161</DOCNO>
	<brief_summary>RATIONALE : Donepezil EGb761 may effective improve neurocognitive function ( thinking , attention , concentration , memory ) may improve quality life patient undergone radiation therapy brain . PURPOSE : This phase II trial study well donepezil EGb761 work improve neurocognitive function patient undergone radiation therapy primary brain tumor brain metastasis .</brief_summary>
	<brief_title>Phase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain Tumor</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine effect donepezil EGb761 neurocognitive function patient underwent radiotherapy primary brain tumor brain metastasis least 6 month study registration . Secondary - Determine toxicity drug patient . - Determine quality life patient treat drug . - Quantify extent radiation-induced white matter disease temporal lobe atrophy patient treat drug . OUTLINE : This open-label , multicenter study . - Group 1 ( close accrual 10/09/03 ) : Patients receive oral donepezil daily 24 week . - Group 2 : Patients receive oral EGb761 three time daily 24 week . In group ( group 1 close accrual 10/09/03 ) , treatment continue absence unacceptable toxicity . In group ( group 1 close accrual 10/09/03 ) , quality life neurocognitive assessment perform baseline week 6 ( group 1 ) , 12 , 24 , 30 . Patients follow 6 week . PROJECTED ACCRUAL : A total 70 patient ( 35 per treatment group ) accrue study within 9.5 month . ( Group 1 close accrual 10/09/03 )</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Radiation Injuries</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis primary brain tumor brain metastasis , meet 1 follow criterion : No radiographic evidence disease Stable disease , define tumor progression within past 3 month Previously treat 1 course localize whole brain radiotherapy least 3,000 cGy least 6 month study registration PATIENT CHARACTERISTICS : Age 18 Performance status Karnofsky 70100 % Life expectancy At least 30 week Hematopoietic Not specify Hepatic Not specify Renal Not specify Other Not pregnant nursing Negative pregnancy test PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No concurrent chemotherapy Endocrine therapy Concurrent steroid therapy allow stable decrease dose Radiotherapy See Disease Characteristics No concurrent cranial radiotherapy Surgery No concurrent surgery Other More 3 month since prior donepezil EGb761 No concurrent donepezil ( group 2 ) No concurrent EGb761 ( group 1 ) ( close accrual 10/09/03 ) No concurrent anticoagulant ( e.g. , aspirin , dipyridamole , heparin , warfarin , enoxaparin ) ( group 2 ) No concurrent monoamine oxidase inhibitor ( e.g. , phenelzine tranylcypromine ) No concurrent therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>radiation toxicity</keyword>
	<keyword>adult mixed glioma</keyword>
	<keyword>adult central nervous system germ cell tumor</keyword>
	<keyword>adult brain stem glioma</keyword>
	<keyword>adult craniopharyngioma</keyword>
	<keyword>adult medulloblastoma</keyword>
	<keyword>adult meningioma</keyword>
	<keyword>adult choroid plexus tumor</keyword>
	<keyword>adult tumor metastatic brain</keyword>
	<keyword>adult anaplastic oligodendroglioma</keyword>
	<keyword>adult anaplastic astrocytoma</keyword>
	<keyword>adult pilocytic astrocytoma</keyword>
	<keyword>adult subependymoma</keyword>
	<keyword>adult meningeal hemangiopericytoma</keyword>
	<keyword>adult ependymoblastoma</keyword>
	<keyword>adult anaplastic ependymoma</keyword>
	<keyword>adult pineoblastoma</keyword>
	<keyword>adult pineocytoma</keyword>
	<keyword>adult myxopapillary ependymoma</keyword>
	<keyword>adult glioblastoma</keyword>
	<keyword>adult grade III meningioma</keyword>
	<keyword>adult oligodendroglioma</keyword>
	<keyword>adult giant cell glioblastoma</keyword>
	<keyword>adult gliosarcoma</keyword>
	<keyword>adult ependymoma</keyword>
</DOC>